F13.921
Sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium
Clinical Classification Guidelines
Inclusion Terms
- Sedative, hypnotic, or anxiolytic-induced delirium
Medical Intelligence & Overview
ICD-10 code F13.921 refers to a condition where an individual experiences delirium caused by the use of sedatives, hypnotics, or anxiolytics. These medications are often prescribed to help with anxiety, sleep issues, or to sedate a patient before medical procedures. However, in some cases, their use can lead to adverse effects, including a state of confusion or delirium. This guide provides an overview of this condition, highlighting its causes, symptoms, and ways it is typically diagnosed and managed.
Causes & Symptoms
Clinical Causes: Excessive or accidental overdose of sedative, hypnotic, or anxiolytic medications. Sensitivity or allergic reaction to these medications. Interaction of these drugs with other substances such as alcohol or other central nervous system depressants. Pre-existing mental or physical health conditions that increase susceptibility to delirium. Rapid dose escalation or abrupt discontinuation of medication. Underlying liver or kidney dysfunction affecting drug metabolism.
Key Symptoms: Sudden confusion or disorientation Altered consciousness or awareness Difficulty focusing or maintaining attention Hallucinations or illusions Agitation or restlessness Altered sleep-wake cycles Fluctuating levels of consciousness Physical signs such as tremors or abnormal movements in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing sedative, hypnotic, or anxiolytic-induced delirium involves a comprehensive clinical assessment. Healthcare providers will review the patient's medication history, including recent changes in dosage. They may perform physical examinations and laboratory tests to rule out other causes of delirium, such as infections, metabolic imbalances, or neurological issues. The diagnosis is primarily clinical, supported by the patient's current medication usage and the rapid onset of symptoms following medication use.
Treatment Protocols: Management of this condition generally includes the following approaches:
Clinical Advice & FAQs
Billing Guidance
Is F13.921 a billable ICD-10 code?
Yes, F13.921 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.921?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference